[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 166,168,960
  • Shares Outstanding, K 1,741,813
  • Annual Sales, $ 44,328 M
  • Annual Income, $ 6,524 M
  • EBIT $ 9,389 M
  • EBITDA $ 12,505 M
  • 60-Month Beta 0.61
  • Price/Sales 3.62
  • Price/Cash Flow 13.19
  • Price/Book 3.05

Options Overview Details

View History
  • Implied Volatility 36.36% (+0.70%)
  • Historical Volatility 27.26%
  • IV Percentile 99%
  • IV Rank 97.20%
  • IV High 36.92% on 06/11/26
  • IV Low 16.97% on 08/12/25
  • Expected Move (DTE 7) 2.65 (2.78%)
  • Put/Call Vol Ratio 0.32
  • Today's Volume 11,218
  • Volume Avg (30-Day) 15,439
  • Put/Call OI Ratio 0.68
  • Today's Open Interest 229,587
  • Open Int (30-Day) 247,590
  • Expected Range 92.75 to 98.05

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.28
  • Number of Estimates 7
  • High Estimate $1.28
  • Low Estimate $1.27
  • Prior Year $1.26
  • Growth Rate Est. (year over year) +1.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
86.72 +10.01%
on 06/03/26
95.74 -0.36%
on 07/02/26
+8.43 (+9.69%)
since 06/02/26
3-Month
81.97 +16.38%
on 05/11/26
103.83 -8.12%
on 04/08/26
-7.47 (-7.26%)
since 04/02/26
52-Week
81.97 +16.38%
on 05/11/26
137.49 -30.61%
on 09/22/25
-38.71 (-28.86%)
since 07/02/25

Most Recent Stories

More News
Quest Diagnostics's Q2 2026 Earnings: What to Expect

Quest Diagnostics is expected to unveil its second-quarter results later this month, and analysts expect a single-digit growth in earnings.

ABT : 95.40 (+3.49%)
XLV : 163.74 (+2.63%)
DGX : 215.72 (-0.14%)
$SPX : 7,483.24 (unch)
Wall Street Says to Buy These 3 Dividend Aristocrats

Analysts are generally favorable when it comes to companies that boast at least a quarter-century of uninterrupted dividend growth, but these are some of their highest-rated names.

TGT : 130.21 (-0.06%)
ABT : 95.40 (+3.49%)
ABBV : 261.07 (+3.99%)
WMT : 111.84 (+2.78%)
Abbott Laboratories' Q2 2026 Earnings: What to Expect

Abbott Laboratories is scheduled to report its second-quarter results in July, and analysts expect a single-digit earnings rise.

ABT : 95.40 (+3.49%)
XLV : 163.74 (+2.63%)
$SPX : 7,483.24 (unch)
Abbott hosts conference call for second-quarter earnings

ABBOTT PARK, Ill. , June 25, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2026 financial results on Thursday, July 16, before the market opens.

ABT : 95.40 (+3.49%)
ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing

ALZpath Strengthens Market Leadership with Abbott Agreement to Help Enable Early Alzheimer's Diagnosis at Global Scale

ABT : 95.40 (+3.49%)
New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents

ABBOTT PARK, Ill. , June 22, 2026 /PRNewswire/ -- Parenthood is widely anticipated as one of life's most fulfilling journeys, yet for today's new parents – especially Gen Z – that excitement...

ABT : 95.40 (+3.49%)
Is STERIS Stock Underperforming the Dow?

While STERIS has underperformed relative to the Dow over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

ABT : 95.40 (+3.49%)
STE : 218.20 (+2.78%)
$DOWI : 52,900.07 (+1.14%)
Abbott declares 410th consecutive quarterly dividend

ABBOTT PARK, Ill. , June 12, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share.

ABT : 95.40 (+3.49%)
When Investors Finally Get Sick of AI Stocks, This Medical Devices ETF Could Be a Long-Term Winner

Over the long term, the IHI ETF looks like a good turnaround story.

ABT : 95.40 (+3.49%)
SYK : 326.54 (+4.20%)
IHI : 51.88 (+3.80%)
ISRG : 426.01 (+5.87%)
New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers

NEW ORLEANS , June 8, 2026 /PRNewswire/ -- New research presented at the American Diabetes Association's 86 th Scientific Sessions showed that adults living with type 2 diabetes participating...

ABT : 95.40 (+3.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 100.62
2nd Resistance Point 98.18
1st Resistance Point 96.79
Last Price 95.40
1st Support Level 92.96
2nd Support Level 90.52
3rd Support Level 89.13

See More

52-Week High 137.49
Fibonacci 61.8% 116.28
Fibonacci 50% 109.73
Fibonacci 38.2% 103.18
Last Price 95.40
52-Week Low 81.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.